Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Gilead Sciences (GB:0QYQ)
LSE:0QYQ
0QYQ Analyst Ratings
Moderate Buy
16 Buy
10 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
0QYQ Stock 12 Month Forecast
Average Price Target
$100.05
▲(2.73% Upside)
| Highest Price Target$125.00 | Average Price Target$100.05 | Lowest Price Target$73.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
RBC Capital
Reiterated
02/03/25
Bernstein
Assigned
01/30/25
J.P. Morgan
Reiterated
01/29/25
TD Cowen
Assigned
01/29/25
Wells Fargo
Reiterated
01/23/25
Jefferies
Reiterated
01/22/25
Morgan Stanley
Reiterated
01/16/25
Citi
Reiterated
01/16/25
Truist Financial
Assigned
12/13/24
Piper Sandler
Assigned
12/12/24
Deutsche Bank
$73
Hold
-25.04%
Downside
Reiterated
12/11/24
Deutsche Bank reiterates Hold Rating on Gilead Sciences (GILD)Deutsche Bank analyst James Shin reiterated a Hold rating and $73.00 price target on Gilead Sciences (NASDAQ: GILD).
Leerink Partners
$99
Buy
1.65%
Upside
Assigned
12/11/24
Gilead Sciences (GILD) PT Raised to $99 at Leerink PartnersLeerink Partners analyst Andrew Berens raised the price target on Gilead Sciences (NASDAQ: GILD) to $99.00 (from $96.00) while maintaining a Outperform rating.
Bank of America Securities
$109
Buy
11.92%
Upside
Initiated
12/10/24
BofA Securities resumes Gilead Sciences (GILD) at BuyBofA Securities analyst Tim Anderson resumes coverage on Gilead Sciences (NASDAQ: GILD) with a Buy rating and a price target of $109.00.
Wolfe Research
$109
Buy
11.92%
Upside
Initiated
12/10/24
Gilead reinstated with a Buy at BofAGilead reinstated with a Buy at BofA
Mizuho Securities
―
Buy
―
Assigned
12/10/24
Gilead Sciences' Anito-Cel Shows Promising Efficacy and Safety in Phase 2 Trial, Earning Buy Rating
Best Analysts Covering Gilead Sciences
Which Analyst Should I Follow If I Want to Buy GB:0QYQ and Sell After:
1 Month
xxx
Success Rate
18/28 ratings generated profit
Average Return
+1.49%
assigned a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 64.29% of your transactions generating a profit, with an average return of +1.49% per trade.
3 Months
xxx
Success Rate
18/28 ratings generated profit
Average Return
+3.10%
assigned a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 64.29% of your transactions generating a profit, with an average return of +3.10% per trade.
1 Year
Success Rate
19/28 ratings generated profit
Average Return
+12.94%
assigned a buy rating 7 days ago
Copying Tyler Van Buren's trades and holding each position for 1 Year would result in 67.86% of your transactions generating a profit, with an average return of +12.94% per trade.
2 Years
xxx
Success Rate
48/58 ratings generated profit
Average Return
+18.64%
reiterated a xxx
rating 14 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 82.76% of your transactions generating a profit, with an average return of +18.64% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
0QYQ Analyst Recommendation Trends
Rating
Oct 24
Nov 24
Dec 24
Jan 25
Feb 25
Strong Buy
0
0
0
0
0
Buy
26
31
37
40
25
Hold
28
27
24
20
8
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
54
58
61
60
33
Each month's total comprises the sum of three months' worth of ratings.
0QYQ Financial Forecast
0QYQ Stock Forecast FAQ
What is GB:0QYQ’s average 12-month price target, according to analysts?
Based on analyst ratings, Gilead Sciences’s 12-month average price target is $100.05.
What is GB:0QYQ’s upside potential, based on the analysts’ average price target?
Gilead Sciences has 2.73% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Gilead Sciences a Buy, Sell or Hold?
Gilead Sciences has a consensus rating of Moderate Buy, which is based on 16 buy ratings, 10 hold ratings and 0 sell ratings.
What is Gilead Sciences’s share price target?
The average share price target for Gilead Sciences is $100.05. This is based on 26 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $125.00 ,and the lowest forecast is $73.00. The average share price target represents 2.73% Increase from the current price of $97.39.
The highest analyst share price target is $125.00 ,and the lowest forecast is $73.00. The average share price target represents 2.73% Increase from the current price of $97.39.
What do analysts say about Gilead Sciences?
Gilead Sciences’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 26 Wall Streets Analysts.
How can I buy shares of Gilead Sciences?
To buy shares of GB:0QYQ, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.